Latest news from Cochrane
Kangaroo care can save small babies
17 November 2026
Kangaroo care probably reduces deaths and serious infections compared with conventional neonatal care. This effect was especially clear in low-resource settings.
Daily iron supplements reduce iron deficiency anaemia in children and adolescents
17 November 2026
Giving children and adolescents a daily iron tablet significantly reduces the risk of iron deficiency anaemia with little to no effect on several common illnesses, according to a Cochrane review of 114 studies involving more than 50,000 participants.
Cochrane appoints first Chief Community Officer
5 November 2026
The Cochrane Collaboration has appointed its first Chief Community Officer, a dedicated senior role responsible for supporting and engaging Cochrane’s diverse global community.
Governing Board election results
30 October 2026
We are pleased to announce that following the recent Governing Board election Isabelle Boutron, Director of Cochrane France and Moriam Chibuzor, Senior Research Officer at Cochrane Nigeria have been elected.
Reviews to feed into the upcoming WHO guideline on pre-eclampsia – a call for author teams
Cochrane is commissioning a series of new reviews to address priority questions identified by WHO. Given the importance of pre-eclampsia as a major cause of maternal and perinatal morbidity and mortality globally, these reviews have the potential to directly inform international recommendations and clinical practice.
Little evidence that common workplace ergonomics help with pain
28 October 2026
An updated Cochrane review has found that ergonomic interventions show no meaningful benefit for pain, function, recovery or sick leave in workers with work-related complaints of the arm, neck or shoulder (CANS), compared with no treatment.
World Evidence-based Healthcare Day focuses on evidence and AI
20 October 2026
This year, World Evidence-based Healthcare Day is focusing on evidence, artificial intelligence (AI), and keeping people at the centre of health decision-making.
Insufficient evidence to back medical cannabis for insomnia
13 October 2026
A new Cochrane review finds that existing evidence is too uncertain to determine whether medical cannabis improves sleep or daytime functioning in people with insomnia.
Pharmaceutical company marketing negatively influences prescribing
9 October 2026
Doctors’ prescribing habits are heavily influenced by payments, gifts, and free meals from pharmaceutical companies, leading to more expensive, less appropriate and more drugs being prescribed, a new Cochrane review finds.
New tool helps researchers spot problematic trials before they distort evidence
24 September 2026
A tool for assessing the trustworthiness of randomized controlled trials (RCTs) has been published today in The BMJ, giving researchers a structured way to identify problematic studies before they're included in systematic reviews.
Our newsletters
Get regular news about different areas of our work in your inbox. Sign up for a Cochrane account and opt into newsletters in the 'Communications' tab to subscribe.
- Patient and Public Network newsletter: monthly digest for patients and members of the public about health evidence, and helping to create it
- Early Career Professionals Network newsletter: regular resources, training, events, opportunities, features and blogs relevant to Early Career Researchers
- Author Digest: monthly updates and tips on writing systematic reviews
- Cochrane Evidence Synthesis and Methods journal: sign up for alerts on our publisher's website
- Cochrane Library newsletter: updates on new Cochrane Library features, enhancements and the latest evidence. Sign up on our publisher's website.
Media enquiries
Please see our Press office page.




